Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


05 agosto 2016

Biopsy after ablation of colorectal metastases “feasible” to identify local progression

Interventional News

Incomplete tumour treatment and local tumour progression remain important limitations to the widespread use of radiofrequency ablation for colorectal liver metastases. This means it is vital to develop and apply prognostic markers to identify patients at increased risk for local tumour progression after ablation. A new study, recently published in Radiology, finds that biopsy of the ablation zone after ablation is feasible.

05 agosto 2016

UK NICE publishes Medtech Innovation Briefing on Lutonix

Interventional News

The UK National Institute for Health and Care Excellence (NICE) has developed a Medtech Innovation Briefing (MIB) on the Lutonix drug-coated balloon (DCB) for peripheral arterial disease. Lutonix (Bard) is a paclitaxel-coated percutaneous transluminal angioplasty catheter indicated for treating peripheral arterial disease.

16 septiembre 2016

Terumo’s FineDuo microcatheter receives CE mark

Interventional News

FineDuo—a low profile, multifunctional, dual-lumen microcatheter—now has the CE mark. The device has been developed for use during percutaneous transluminal coronary angioplasty for guidewire support for crossing side branch and exchange of guidewires. According to a press release, it provides provide robust support and easy access to complex coronary vasculature.

12 septiembre 2016

BTG launches βETA radiation safety programme at CIRSE 2016

Interventional News

BTG has launched the βETA Radiation Safety Programme, a new initiative designed to reduce the risk of radiation exposure when performing selective internal radiation therapy (SIRT) with 90Y microspheres. Developed in collaboration with global experts, including Jacob Kamen of the Mount Sinai Medical Center, the βETA Radiation Safety Programme analyses current practise and exposure risk, and provides recommendations to improve safety for healthcare professionals and patients.

07 julio 2016

Merit Medical pays US$97.5 million to acquire Dfine

Interventional News

Dfine’s products are directed to vertebral augmentation (kyphoplasty and vertebroplasty), as well as targeted radiofrequency ablation of metastatic spinal tumours and these product lines have 510(k) clearance and CE marking.

31 mayo 2016

Intra-arterial hepatocellular carcinoma treatment at the dawn of systemic therapy

Interventional News

Bruno Sangro, director of the Liver Unit and co-director, of the HPB Oncology Area, Clinca Universidad de Navarra, Pamplona, Spain, delivered the European Conference on Interventional Oncology (ECIO) Honorary Lecture on the topic “Intra-arterial treatment of hepatocellular carcinoma (HCC) at the dawn of systemic therapy”. ECIO took place 17–20 April, in Dublin, Ireland.

31 mayo 2016

Embolization for pain management, lymphatic interventions at the frontline

Interventional News

The role of embolization in musculoskeletal pain management, treatment of haemorrhoidal bleeding and lymphatic interventions were among the highlights of a special session titled The Embolization Vanguard at the Global Embolization Symposium and Technologies (GEST 2016 US, 5–8 May, New York, USA) meeting.

31 mayo 2016

European Union agrees new rules for approving medical devices and in vitro diagnostic medical devices

Interventional News

The Netherlands presidency of the European Council and representatives of the European Parliament have reached a political agreement on two draft regulations for medical devices. The new regulations are aimed at ensuring that medical devices and in vitro diagnostic medical devices are safe while allowing patients to benefit of innovative health care solutions in a timely manner. However, the agreement is subject to the approval by the Council’s Permanent Representatives Committee and of the Parliament’s ENVI committee.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.